Approval - Magic Post

Suzetrigine approval may promote growth – Magic Post

January 20, 2025 - by Magic Post - Leave a Comment

Vertex Pharmaceuticals Nasdaq: Vertex is a biotechnology company with a proven track record of success in developing treatments for cystic fibrosis (CF). Vertex is strategically expanding into the pain management …

Finance

MASH approval could revive GLP-1 sales – Magic Post

December 18, 2024 - by Magic Post - Leave a Comment

Novo Nordisk A/S today Non-governmental organizations Novo Nordisk A/S $108.01 0.00 (0.00%) (As of 10:59 a.m. ET) 52 week range $99.42 ▼ $148.15 Dividend yield 0.67% P/E ratio 34.95 Price …